Apixaban versus Aspirin for Embolic Stroke of Undetermined Source

Tobias Geisler(Imperial College London), Sven Poli(Hertie Institute for Clinical Brain Research), Jan Purrucker(Heidelberg University), A. Lindner(Marienhospital Stuttgart), Jan Liman(Defense Information Systems Agency), Gabor C. Petzold(University Hospital Bonn), L. Niehaus(Rems-Murr-Klinikum), Lina María Serna-­Higuita(University of Tübingen), Hansjörg Bäzner(Klinikum Stuttgart), Jüergen Schreieck(University of Tübingen), Felix J. Bode(University Hospital Bonn), Regina Feurer(Klinikum Ludwigshafen), Brian Mac Grory(Duke University), Hubert Kimmig(Schwarzwald-Baar Klinikum), Thomas Nägele(University of Tübingen), Roman Huber(University of Freiburg), Peter Martus(University of Tübingen), Marc E. Wolf(Heidelberg University), Thanh N. Nguyen(Cleveland Clinic), Khouloud Poli(Hertie Institute for Clinical Brain Research), Paula Bombach(Hertie Institute for Clinical Brain Research), Uwe Klose(University of Tübingen), Werner Jung(Schwarzwald-Baar Klinikum), Timea Keller(University of Tübingen), Ulf Ziemann(TH Bingen University of Applied Sciences), Katharina Althaus(Christophorus Kliniken), Meinrad Gawaz(University of Tübingen), Matthew Schrag(Vanderbilt University), Patrick Groga‐Bada(University of Tübingen), Rolf Wachter(Leipzig University), Johannes Tünnerhoff(Hertie Institute for Clinical Brain Research), Katrin Naupold(Merseburg University of Applied Sciences), Carsten Hobohm(Merseburg University of Applied Sciences), Frank Hoffmann(Martha-Maria Hospital), Parwez Aidery(University of Tübingen), Andrea Kraft(Martha-Maria Hospital), Christine S. Zuern(University Hospital of Basel)
NEJM Evidence
December 22, 2023
Cited by 80


Related Papers